Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Green Light for Genfit to Tackle another Liver Disease
Genfit builds rare liver disease pipeline with Versantis buy | pharmaphorum
GENFIT acquires Swiss biotech Versantis for up to CHF105 million
Genfit : La biotech Genfit va commercialiser aux Etats-Unis son outil ...
Homepage - Genfit
Genfit swallows Versantis in €105m deal - European Biotechnology Magazine
GENFIT on LinkedIn: #aclf #aclf #liverdisease #cirrhosis #raredisease # ...
Genfit Gears Up For Primary Biliary Cholangitis Trial Data
Actualité La société nordiste Genfit fait sensation en bourse , offres ...
GENFIT career: recruitment in biopharmaceutical | GENFIT
Startup GENFIT Une société biopharmaceutique développant des solutions ...
biopharmaceutical company - GENFIT Biotechnologies
GENFIT on LinkedIn: #aclf #liverdisease #raredisease #organfailure # ...
GENFIT on LinkedIn: #aclf #collaboration #easlcongress #hepathology # ...
GENFIT (EPA:GNFT) | GENFIT unveils its future clinical trials and ...
GENFIT | LinkedIn
GENFIT Showcases Innovations in Liver Disease Research at AASLD ...
GENFIT visits EF CLIF to discuss next steps on collaborative liver ...
#guggenheimhealthcare #biotech #biopharma #liverdisease | GENFIT
#pbc #biotech #liverdisease #ema | GENFIT
Genfit dépose les documents en vue de son introduction au Nasdaq - Les ...
Genfit Gets Ready to Launch Drug for NASH Raising €120M
GENFIT (EPA:GNFT) | GENFIT Reveals Encouraging Preclinical Findings on ...
GENFIT (EPA:GNFT)
Expertise - Genfit
Maladies du foie : Genfit se donne les moyens d'accélérer son programme ...
Genfit - Certified B Corporation - B Lab
US FDA grants accelerated approval to Genfit and Ipsen's liver disease ...
Genfit : L'échec d'une molécule de la même famille qu'élafibranor ...
Genfit Delays Data From NASH Study. The Stock Is Falling. - Barron's
Therapeutic Areas - Genfit
EF CLIF partners with GENFIT to advance ACLF research and treatment ...
GENFIT on LinkedIn: #liver #healthy #worldliverday #liverday #hepatology
About Us | Genfit 🟢⚡
Genfit : Ipsen conclut un partenariat avec Genfit valorisant la biotech ...
Genfit Plunges as Liver Medicine Falls Short in Study - Bloomberg
GENFIT Launches a Phase 2 Trial Evaluating Elafibranor
Genfit - GreenExpo
SPECIAL ACTIONS – Genfit : une biotech française en bonne santé ! - DT ...
Genfit : Une trésorerie confortable de 290 millions d'euros pour ...
Genfit set to raise $100m in Nasdaq IPO - European Biotechnology Magazine
GENFIT présente le design de ses prochains essais cliniques et rappelle ...
About - Genfit
Projects - Genfit
Genfit : des résultats positifs dans la cholangite biliaire primitive ...
Genfit : La biotech française Genfit veut lever plus de 100 millions de ...
Genfit Gets €180M Cash Injection to Bring its Pipeline to Market
Genfit advances pipeline for acute-on-chronic liver failure | BioWorld
GENFIT on LinkedIn: Innovations in Hepatic Encephalopathy & ACLF: Key ...
Genfit : La biotech tricolore Genfit donne le coup d'envoi d'une IPO au ...
LabCorp inks licensing pact for Genfit liver test | MedTech Dive
Biotech : Genfit s'effondre en Bourse après l'échec d'un essai clinique ...
GENFIT (EPA:GNFT) | GENFIT: Positive Opinion from EMA Committee for ...
Action Genfit : acheter aujourd’hui ou patienter ? Analyse et conseils 2025
Ipsen, Genfit Medicine Elafibrano Is Cleared by FDA to Treat Rare Liver ...
#healthtech #licensing | GENFIT
GENFIT - Clubster NSL
Genfit builds rare liver disease pipeline with Versantis buy – gr-cis.com
Genfit expanding liver diseases portfolio | The Pharmaletter
GENFIT - Eurasanté
Acute-on-Chronic Liver Failure (ACLF) - Genfit
Genfit : à suivre
As Genfit hopes to get its liver drug on the market, founding CEO makes ...
Liver specialist Genfit files $120m IPO on Nasdaq - PMLiVE
Genfit : un rêve envolé, mais une consolation - Investir
GENFIT appoints new chief medical officer | The Pharmaletter
Genfit France
Genfit in $228m deal with Terns Pharmaceuticals - European ...
Genfit : En raison d'un cas de péritonite, Genfit arrête les frais pour ...
GENFIT Celebrates EU Approval of Iqirvo® for Liver Disease Treatment ...
Ahead of key NASH readout, France’s Genfit readies plans for $100M US IPO
Genfit dans le vert avec des données précliniques dans l'ACLF - 10/11 ...
Genfit - Finorpa
Genfit - LifeScienceHistory.com
Genfit : L'Elafibranor désormais commercialisé sur le marché américain ...
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an ...
#liverdisease #research #medicine #lifesciences | Morse
Succès pour la biotech Genfit, qui s’allie à Ipsen
#expertise #drugdiscovery #breakthroughs #liverdisease #raredisease # ...
Detail - Swiss Trade
Liver Fibrosis Market Size to Reach USD 5.4 Billion by 2035, Impelled ...
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary ...
GENFIT, NASH 환자 식별 비침습적 진단기법 출시 간질환 진단 통해 선제적 관리 가능 기대 - Zymedi
Genfit: Iqirvo's Success Can't Outweigh ACLF Pipeline Risks (NASDAQ ...
SolarEdge Roadshow 2024: Illuminating the Future of Solar Technology
#biofit #healthcareinnovation #genfit #sustainablehealthcare # ...
#easlcongress #aclf #easl #hepathology #liverdisease # ...
GENFIT: Major Milestone for the RESOLVE-IT Phase 3 Trial on the ...
Genfit's Non-Invasive Diagnostic could unlock the NASH Market
Advancing France's Health Industry with Nord France Invest
Genfit, la « pépite » lilloise des biotechs qui inquiète
«Дженфит» (Genfit) | МОСМЕДПРЕПАРАТЫ
Elafibranor – New Drug Approvals
196 Biopharmaceutical Industry Stock Photos, High-Res Pictures, and ...